Status | Study |
Terminated |
Study Name: Longitudinal Analysis of Plasmodium Falciparum-Specific Immunity in Travelers and Immigrants From Malaria Endemic Areas to the United States Condition: Malaria Date: 2014-05-31 |
Completed |
Study Name: Controlled Human Malaria Infection After Bites From Mosquitoes Infected With Two Novel P. Falciparum Strains Condition: Malaria Date: 2014-05-26 Interventions: Other: NF135 n=5 Subjects will |
Completed |
Study Name: Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2) Condition: Malaria Date: 2013-09-03 Interventions: Drug: Mefloquine - Artesunate |
Recruiting |
Study Name: Intravenous Artesunate and Malaria Condition: Malaria Date: 2013-03-02 Interventions: Drug: artesunate intravenous a |
Terminated |
Study Name: Malaria Prevention Cambodia Condition: Malaria Date: 2012-06-17 Interventions: Drug: DHA-piperaquine |
Completed |
Study Name: Comparison of Three Plasmodium Falciparum Isolates in a Controlled Human Malaria Infection Condition: Malaria Date: 2012-05-25 Interventions: Other: NF54 Volunteers will be |
Completed |
Study Name: Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults Condition: Malaria Date: 2012-02-09 Interventions: Biological: Group 1: 10 ug FMP012 with 2 ug GLA-SE |
Completed |
Study Name: Chloroquine for Malaria in Pregnancy Condition: Malaria Date: 2011-09-01 Interventions: Drug: Chloroquine Chloroquine |
Completed |
Study Name: Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children Condition: Malaria Date: 2011-02-24 Interventions: Biological: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine (257049) 4 different lots o |
Completed |
Study Name: Malaria Active Epidemiology and Treatment Study Condition: Malaria Date: 2011-01-19 Interventions: Drug: Dihydroartemisinin piperaquine 40/320 mg tablets, 9 tablets total |